Medicine guide

Ticagrelor Liconsa 60 mg filmomhulde tabletten

As listed in the register: Ticagrelor Liconsa 60 mg filmomhulde tabletten

60 mg · filmomhulde tablet

  • Prescription only
  • Blood, clotting and anaemia
Active substance
Ticagrelor
Made by
Laboratorios Liconsa S.A.

Quoted from the official source. Not yet reviewed by Mediclarum — the leaflet in your pack is authoritative.

What it is for

Medicine groupBlood, clotting and anaemiaB01AC24

Mediclarum has not yet retrieved and stored the official label for this product, so none of its text is shown here. Open the official leaflet

How it works

This product’s leaflet is published as a scanned document. This section quotes the US prescribing label for the same active substance (ticagrelor). It describes the substance, not this Bulgarian product — its uses and doses can differ.

Ticagrelor and its major metabolite reversibly interact with the platelet P2Y 12 ADP-receptor to prevent signal transduction and platelet activation.

Ticagrelor and its active metabolite are approximately equipotent.

With food

Ticagrelor can be taken with or without food.

Quoted from the prescribing label, sections “Mechanism of Action” and “Pharmacokinetics”. DailyMed · 2026-08-27

Safety of the active substance

This product’s leaflet is published as a scanned document. This section quotes the US prescribing label for the same active substance (ticagrelor). It describes the substance, not this Bulgarian product — its uses and doses can differ.

Serious warning

WARNING: BLEEDING RISK Ticagrelor, like other antiplatelet agents, can cause significant, sometimes fatal bleeding ( 5.1, 6.1 ).

Must not be used by
  • History of intracranial hemorrhage.
  • ( 4.1 ) Active pathological bleeding.
  • ( 4.2 ) Hypersensitivity to ticagrelor or any component of the product.
Most common side effects

Most common adverse reactions (>5%) are bleeding and dyspnea.

Quoted from the US prescribing label for the same active substance. Your own pack’s leaflet is the authority for your product. DailyMed

Same active substance, strength and form in other countries

Matched on active substance, strength and kind of form only. This is not a statement that the products are equivalent or interchangeable: other ingredients, release and approved uses can differ — ask a pharmacist before swapping.

Medicine passport: one printable page to show a pharmacist abroad

European UnionNo exact match for this strength and form

SwitzerlandNo exact match for this strength and form

Details

Made byLaboratorios Liconsa S.A.
Active substanceTicagrelor
Used inBlood, clotting and anaemia
Strength60 mg
Formfilmomhulde tablet
ClassificationB01AC24 · Blood, clotting and anaemia
Routeoraal gebruik
Dispensing (as stated by the register)Uitsluitend recept
RVG130931

Source: Geneesmiddeleninformatiebank · 2026-09-30 · not reviewed by a clinician

Bron: College ter Beoordeling van Geneesmiddelen (CBG). De Rijksoverheid is het niet automatisch eens met de inhoud van deze site. Reuse terms: CC0 1.0 (CBG website).

Other strengths and forms

2 products are sold under this name. Grouped by form; a number on a strength means several companies make it.

Same active substance

These contain the same substance. That does not mean one can replace another — ask a pharmacist.